NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency

Clinical Genetics

Volumn 89, Issue 5, 2016, Pages 608-613

  Bouali, N ^a   Francou, B ^b,c   Bouligand, J ^b,c   Lakhal, B ^a   Malek, I ^a   Kammoun, M ^a   Warszawski, J ^b   Mougou, S ^a   Saad, A ^a   Guiochon Mantel, A ^b,c  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

BMP15; GDF9; NOBOX; Primary ovarian insufficiency

Indexed keywords

ARGININE; BONE MORPHOGENETIC PROTEIN 15; GLYCINE; GROWTH DIFFERENTIATION FACTOR 9; GROWTH FACTOR; LEUCINE; NOBOX PROTEIN; PROLINE; TRYPTOPHAN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; NOBOX PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOME; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIAN; ALLELE; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PRIMARY OVARIAN INSUFFICIENCY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TUNISIA;

ADULT; ALLELES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; MUTATION, MISSENSE; PREVALENCE; PRIMARY OVARIAN INSUFFICIENCY; TRANSCRIPTION FACTORS; TUNISIA;

EID: 84959575073     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12750     Document Type: Article

References (19)

1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986: 67: 604-606.
2. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol 2010: 45: 257-279.
3. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure overview of selected candidate genes. Ann NY Acad Sci 2008: 1135: 146-154.
4. Huntriss J, Hinkins M, Picton HM. cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Mol Hum Reprod 2006: 12: 283-289.
5. Choi Y, Rajkovic A. Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem 2006: 281: 35747-35756.
6. Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N. Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum Mutat 2011: 32: 1108-1113.
7. Bouilly J, Roucher-Boulez F, Gompel A et al. New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression. J Clin Endocrinol Metab 2014: 100: 994-1001.
8. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 2004: 25: 72-101.
9. Persani L, Rossetti R, Di Pasquale E, Cacciatore C, Fabre S. The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders. Hum Reprod Update 2014: 20: 869-883.
10. Dixit H, Rao LK, Padmalatha VV et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 2006: 119: 408-415.
11. Laissue P, Christin-Maitre S, Touraine P et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 2006: 154: 739-744.
12. Qin Y, Jiao X, Simpson L, Chen ZJ. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update 2015: 21: 787-808.
13. Bouali N, Hmida D, Mougou S et al. Analysis of FMR1 gene premutation and X chromosome cytogenetic abnormalities in 100 Tunisian patients presenting premature ovarian failure. Ann Endocrinol 2015: 76: 671-678.
14. Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA 2002: 99: 8060-8065.
15. Gilchrist RB, Ritter LJ, Cranfield M et al. Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity. Biol Reprod 2004: 71: 732-739.
16. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002: 23: 787-823.
17. Rossetti R, Di-Pasquale E, Marozzi A et al. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat 2009: 30: 804-810.
18. Ma L, Chen Y, Mei S et al. Single nucleotide polymorphisms in premature ovarian failure - associated genes in a Chinese Hui population. Mol Med Rep 2015: 12: 2529-2538.
19. Fonseca DJ, Ortega-Recalde O, Esteban-Perez C et al. BMP15 c.-9C>G promoter sequence variant may contribute to the cause of non-syndromic premature ovarian failure. Reprod Biomed Online 2014: 29: 627-633.